
In this episode of Reset Recharge, Dr. Komal Patil-Sisodia explores a groundbreaking study that reveals how menopause hormone therapy (MHT) may actually reduce the risk of type 2 diabetes in perimenopausal women with prediabetes.
Dr. Komal unpacks the data from a major Diabetes and Metabolism study of over 6,500 women aged 46–60, showing that those who used hormone therapy were 30% less likely to develop diabetes. She explains the science behind how estrogen supports metabolic health — improving insulin sensitivity, lowering inflammation, reducing central fat gain, and supporting pancreatic function — and why timing, age, BMI, and ethnicity make all the difference.
You’ll learn:
- How estrogen affects blood sugar and fat distribution
- Why MHT works best when started near menopause
- Which hormone formulations and delivery routes are safest and most effective
- Why personalized, evidence-based care is key to menopause medicine
Whether you’re navigating perimenopause, supporting patients, or simply curious about hormone health, this episode breaks down complex science into practical takeaways you can use.
💡 Key takeaway: Menopause hormone therapy isn’t just about symptom relief — it can be metabolic protection for the right woman, at the right time.
Connect with me:
Eastside Menopause & Metabolism
Time Stamps:
00:00 – 00:54 | Welcome & Episode Overview
00:55 – 02:30 | The Study That Sparked the Conversation
02:31 – 04:00 | Who Benefits Most from Hormone Therapy
04:01 – 06:00 | How Estrogen Supports Metabolic Health
06:01 – 07:45 | The Timing Hypothesis Explained
07:46 – 09:15 | Type & Route of Hormone Therapy Matter
09:16 – 10:45 | Balancing Benefits and Risks
10:46 – 12:15 | The Takeaway: Personalized Menopause Care
12:16 – 13:06 | Closing & Next Steps
References:
Thanks for listening. Find more info about Reset Recharge on the website or Instagram.
Weitere Episoden von „Reset Recharge“



Verpasse keine Episode von “Reset Recharge” und abonniere ihn in der kostenlosen GetPodcast App.







